The Risks and Benefits of Implementing Glycemic Control Guidelines in Frail Older Adults with Diabetes Mellitus
The Risks and Benefits of Implementing Glycemic Control Guidelines in Frail Older Adults with Diabetes Mellitus
复制标题
DOI:
10.1111/j.1532-5415.2011.03362.x
复制
发表时间:
2011-04-01
影响因子:
6.3
通讯作者:
Eng, Catherine
中科院分区:
文献类型:
--
作者:
Lee, Sei J.;Boscardin, W. John;Eng, Catherine
OBJECTIVESTo determine the hypo- and hyperglycemic outcomes associated with implementing the American Geriatrics Society (AGS) guideline for a glycosylated hemoglobin (HbA1c) level of less than 8% in frail older adults with diabetes mellitus (DM).DESIGNGuideline implementation.SETTINGProgram of All-Inclusive Care for the Elderly.PARTICIPANTSAll participants in the before (October 2002-December 2004, n=338), early (January 2005-June 2006, n=289) and late (July 2006-December 2008, n=385) periods of guideline implementation with a diagnosis of DM and at least one HbA1c measurement.INTERVENTIONClinician education in 2005 with annual monitoring of the proportion of each clinician's patients with DM with HbA1c less than 8%.MEASUREMENTSHypoglycemia (blood glucose < 50 mg/dL), hyperglycemia (blood glucose > 400 mg/dL), and severe hypoglycemia (emergency department (ED) visit for hypoglycemia).RESULTSParticipants in the before, early, and late periods were similar in age, race and ethnicity, comorbidities, and functional dependence. Antihyperglycemic medication use was greater in the late period, with more participants using metformin (28% before, 42% late, P